GIRK channels mediate the nonphotic effects of exogenous melatonin

Journal of Neuroscience

Volumn 35, Issue 45, 2015, Pages 14957-14965

  Hablitz, Lauren M ^a   Molzof, Hylton E ^a   Abrahamsson, Xkathryn E ^b   Cooper, Joanna M ^b   Prosser, Rebecca A ^b   Gamble, Xkaren L ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF TENNESSEE   (United States)

Author keywords

Circadian; Entrainment; GIRK; Melatonin; Nonphotic; Suprachiasmatic nucleus

Indexed keywords

G PROTEIN COUPLED INWARDLY RECTIFYING POTASSIUM CHANNEL; MELATONIN; BEE VENOM; INDENE DERIVATIVE; POTASSIUM CHANNEL BLOCKING AGENT; RAMELTEON; TERTIAPIN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; MALE; MOUSE; NERVE POTENTIAL; NERVOUS SYSTEM ELECTROPHYSIOLOGY; NONHUMAN; PRIORITY JOURNAL; SUPRACHIASMATIC NUCLEUS; AGONISTS; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; DRUG EFFECTS; KNOCKOUT MOUSE; ORGAN CULTURE TECHNIQUE; PHYSIOLOGY;

ANIMALS; BEE VENOMS; G PROTEIN-COUPLED INWARDLY-RECTIFYING POTASSIUM CHANNELS; INDENES; MALE; MELATONIN; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; ORGAN CULTURE TECHNIQUES; POTASSIUM CHANNEL BLOCKERS; SUPRACHIASMATIC NUCLEUS;

EID: 84946924217     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.1597-15.2015     Document Type: Article

References (80)

1. Agez L, Laurent V, Pévet P, Masson-Pévet M, Gauer F (2007) Melatonin affects nuclear orphan receptorsmRNAin the rat suprachiasmatic nuclei. Neuroscience 144:522–530. CrossRef Medline
2. Agez L, Laurent V, Guerrero HY, Pévet P, Masson-Pévet M, Gauer F (2009) Endogenous melatonin provides an effective circadian message to both the suprachiasmatic nuclei and the pars tuberalis of the rat. J Pineal Res 46:95–105. CrossRef Medline
3. Arora D, Hearing M, Haluk DM, Mirkovic K, Fajardo-Serrano A, Wessendorf MW, Watanabe M, Luján R, WickmanK (2011) Acute cocaine exposure weakens GABA(B) receptor-dependent G-protein-gated inwardly rectifying K signaling in dopamine neurons of the ventral tegmental area. J Neurosci 31:12251–12257. CrossRef Medline
4. Banach M, Gurdziel E, Je˛drych M, Borowicz KK (2011) Melatonin in experimental seizures and epilepsy. Pharmacol Rep 63:1–11. Medline
5. Benloucif S, Dubocovich ML (1996) Melatonin and light induce phase shifts of circadian activity rhythms in the C3H/HeN mouse. J Biol Rhythms 11:113–125. CrossRef Medline
6. Besing RC, Hablitz LM, Paul JR, Johnson RL, Prosser RA, Gamble KL (2012) Neuropeptide Y-induced phase shifts of PER2::LUC rhythms are mediated by long-term suppression of neuronal excitability in a phase-specific manner. Chronobiol Int 29:91–102. CrossRef Medline
7. Biello SM (2009) Circadian clock resetting in the mouse changes with age. Age (Dordr) 31:293–303. CrossRef Medline
8. Bonnefont-Rousselot D, Collin F (2010) Melatonin: action as antioxidant and potential applications in human disease and aging. Toxicology 278: 55–67. CrossRef Medline
9. Borja NL, Daniel KL (2006) Ramelteon for the treatment of insomnia. Clin Ther 28:1540 –1555. CrossRef Medline
10. Campos Costa I, Nogueira Carvalho H, Fernandes L (2013) Aging, circadian rhythms and depressive disorders: a review. Am J Neurodegener Dis 2:228–246. Medline
11. Challet E (2007) Minireview: entrainment of the suprachiasmatic clockwork in diurnal and nocturnal mammals. Endocrinology 148:5648–5655. CrossRef Medline
12. Cho CH (2012) Molecular mechanism of circadian rhythmicity of seizures in temporal lobe epilepsy. Front Cell Neurosci 6:55. Medline
13. Churchill SS, Kieckhefer GM, Landis CA, Ward TM (2012) Sleep measurement and monitoring in children with Down syndrome: a review of the literature, 1960–2010. Sleep Med Rev 16:477–488. CrossRef Medline
14. Comai S, Gobbi G (2014) Unveiling the role of melatonin MT2 receptors in sleep, anxiety and other neuropsychiatric diseases: a novel target in psychopharmacology. J Psychiatry Neurosci 39:6–21.
15. CrossRef Coomans CP, Ramkisoensing A, Meijer JH (2014) The suprachiasmatic nuclei as a seasonal clock. Front Neuroendocrinol 37:29–42.
16. Days E, Kaufmann K, Romaine I, Niswender C, Lewis M, Utley T, Du Y, Sliwoski G, Morrison R, Dawson ES, Engers JL, Denton J, Daniels JS, Sulikowski GA, Lindsley CW, Weaver CD (2010) Discovery and characterization of a selective activator of the G-protein activated inwardrectifying potassium (GIRK) channel. Updated March 14, 2013. In: Probe reports from the NIH molecular libraries program [Internet]. Bethesda: National Center for Biotechnology Information. Available at http://www.ncbi.nlm.nih.gov/books/NBK143539/
17. Dubocovich ML (2007) Melatonin receptors: role on sleep and circadian rhythm regulation. Sleep Med 8:34–42. Medline
18. Dubocovich ML, Markowska M (2005) Functional MT1 and MT2 melatonin receptors in mammals. Endocrine 27:101–110.
19. CrossRef Dubocovich ML, Rivera-Bermudez MA, Gerdin MJ, Masana MI (2003) Molecular pharmacology, regulation and function of mammalian melatonin receptors. Front Biosci 8:d1093–1108. CrossRef Medline
20. Dubocovich ML, Hudson RL, Sumaya IC, Masana MI, Manna E (2005) Effect of MT1 melatonin receptor deletion on melatonin-mediated phase shift of circadian rhythms in the C57BL/6 mouse. J Pineal Res 39:113–120. CrossRef Medline
21. Fowler CE, Aryal P, Suen KF, Slesinger PA (2007) Evidence for association of GABA(B) receptors with Kir3 channels and regulators. J Physiol 580: 51–65. CrossRef Medline
22. Fu LY, Acuna-Goycolea C, van den Pol AN (2004) Neuropeptide Y inhibits hypocretin/orexin neurons by multiple presynaptic and postsynaptic mechanisms: tonic depression of the hypothalamic arousal system. J Neurosci 24:8741–8751. CrossRef Medline
23. Furuya M, Miyaoka T, Yasuda H, Yamashita S, Tanaka I, Otsuka S, Wake R, Horiguchi J (2012) Marked improvement in delirium with ramelteon: five case reports. Psychogeriatrics 12:259–262. CrossRef Medline
24. García JJ, López-Pingarrón L, Almeida-Souza P, Tres A, Escudero P, García- Gil FA, Tan DX, Reiter RJ, Ramírez JM, Bernal-PérezM (2014) Protective effects of melatonin in reducing oxidative stress and in preserving the fluidity of biological membranes: a review. J Pineal Res 56:225–237. CrossRef Medline
25. Hablitz LM, Molzof HE, Paul JR, Johnson RL, Gamble KL (2014) Suprachiasmatic nucleus function and circadian entrainment are modulated by G protein-coupled inwardly rectifying (GIRK) channels. J Physiol 592: 5079–5092. CrossRef Medline
26. Hastings MH, Mead SM, Vindlacheruvu RR, Ebling FJ, Maywood ES, Grosse J (1992) Non-photic phase shifting of the circadian activity rhythm of Syrian hamsters: the relative potency of arousal and melatonin. Brain Res 591:20–26.
27. CrossRef
28. Hatta K, Kishi Y, Wada K, Takeuchi T, Odawara T, Usui C, Nakamura H; DELIRIA-J Group (2014) Preventive effects of ramelteon on delirium: a randomized placebo-controlled trial. JAMA Psychiatry 71:397–403. CrossRef Medline
29. Huhman KL, Albers HE (1994) Neuropeptide Y microinjected into the suprachiasmatic region phase shifts circadian rhythms in constant darkness. Peptides 15:1475–1478. CrossRef Medline
30. Hunt AE, Al-Ghoul WM, Gillette MU, Dubocovich ML (2001) Activation of MT(2) melatonin receptors in rat suprachiasmatic nucleus phase advances the circadian clock. Am J Physiol Cell Physiol 280:C110–C118. Medline
31. Jain S, Besag FM (2013) Does melatonin affect epileptic seizures? Drug Saf 36:207–215. CrossRef Medline
32. Jiang ZG, Nelson CS, Allen CN (1995) Melatonin activates an outward current and inhibits Ih in rat suprachiasmatic nucleus neurons. Brain Res 687:125–132. CrossRef Medline
33. Kato K, Hirai K, Nishiyama K, Uchikawa O, Fukatsu K, Ohkawa S, Kawamata Y, Hinuma S, MiyamotoM (2005) Neurochemical properties of ramelteon (TAK-375), a selective MT1/MT2 receptor agonist. Neuropharmacology 48:301–310. CrossRef Medline
34. Kaufmann K, Romaine I, Days E, Pascual C, Malik A, Yang L, Zou B, Du Y, Sliwoski G, Morrison RD, Denton J, Niswender CM, Daniels JS, Sulikowski GA, Xie XS, Lindsley CW, Weaver CD (2013) ML297 (VU0456810), the first potent and selective activator of the GIRK potassium channel, displays antiepileptic properties in mice. ACS Chem Neurosci 4:1278–1286. CrossRef Medline
35. Kobayashi T, Ikeda K (2006) G protein-activated inwardly rectifying potassium channels as potential therapeutic targets. Curr Pharm Des 12:4513–4523. CrossRef Medline
36. Kuhlman SJ, McMahon DG (2004) Rhythmic regulation of membrane potential and potassium current persists in SCN neurons in the absence of environmental input. Eur J Neurosci 20:1113–1117. CrossRef Medline
37. Laudon M, Frydman-Marom A (2014) Therapeutic effects of melatonin receptor agonists on sleep and comorbid disorders. Int J Mol Sci 15: 15924–15950. CrossRef Medline
38. Liu C, Weaver DR, Jin X, Shearman LP, Pieschl RL, Gribkoff VK, Reppert SM (1997) Molecular dissection of two distinct actions of melatonin on the suprachiasmatic circadian clock. Neuron 19:9–102. CrossRef Medline
39. Loddenkemper T, Vendrame M, Zarowski M, Gregas M, Alexopoulos AV, Wyllie E, Kothare SV (2011) Circadian patterns of pediatric seizures. Neurology 76:145–153. CrossRef Medline
40. Lott IT (2012) Neurological phenotypes for Down syndrome across the life span. Prog Brain Res 197:101–121. CrossRef Medline
41. Luchetti F, Canonico B, Betti M, Arcangeletti M, Pilolli F, Piroddi M, Canesi L, Papa S, Galli F (2010) Melatonin signaling and cell protection function. FASEB J 24:3603–3624.
42. CrossRef Lücher C, Slesinger PA (2010) Emerging roles forGprotein-gated inwardly rectifying potassium (GIRK) channels in health and disease. Nat Rev Neurosci 11:301–315. CrossRef Medline
43. McArthur AJ, Gillette MU, Prosser RA (1991) Melatonin directly resets the rat suprachiasmatic circadian clock in vitro. Brain Res 565:158–161. CrossRef Medline
44. McArthur AJ, Hunt AE, Gillette MU (1997) Melatonin action and signal transduction in the rat suprachiasmatic circadian clock: activation of protein kinase C at dusk and dawn. Endocrinology 138:627–634. Medline
45. Miyamoto M (2009) Pharmacology of ramelteon, a selective MT1/MT2 receptor agonist: a novel therapeutic drug for sleep disorders.CNSNeurosci Ther 15:32–51. CrossRef Medline
46. Mundey K, Benloucif S, Harsanyi K, Dubocovich ML, Zee PC (2005) Phasedependent treatment of delayed sleep phase syndrome with melatonin. Sleep 28:1271–1278. Medline
47. Muraki Y, Yamanaka A, Tsujino N, Kilduff TS, Goto K, Sakurai T (2004) Serotonergic regulation of the orexin/hypocretin neurons through the 5-HT1A. J Neurosci 24:7159–7166. CrossRef Medline
48. Nelson CS, Marino JL, Allen CN (1996) Melatonin receptors activate het- eromeric G-protein coupled Kir3 channels. Neuroreport 7:717–720. CrossRef Medline
49. Parekh PK, Ozburn AR, McClung CA (2015) Circadian clock genes: Effects on dopamine, reward and addiction. Alcohol 49:341–349.
50. CrossRef Partch CL, Green CB, Takahashi JS (2014) Molecular architecture of the mammalian circadian clock. Trends Cell Biol 24:90–99. CrossRef Medline
51. Paulis L, Simko F, Laudon M (2012) Cardiovascular effects of melatonin receptor agonists. Expert Opin Investig Drugs 21:1661–1678. CrossRef Medline
52. Pittendrigh CS, Daan S (1976) A functional analysis of circadian pacemakers in nocturnal rodents. J Insect Physiol 46:887–896.
53. Poirel VJ, Boggio V, Dardente H, Pévet P, Masson-Pévet M, Gauer F (2003) Contrary to other non-photic cues, acute melatonin injection does not induce immediate changes of clock gene mRNA expression in the rat suprachiasmatic nuclei. Neuroscience 120:745–755. CrossRef Medline
54. Prosser RA (1998) Neuropeptide Y blocks serotonergic phase shifts of the suprachiasmatic circadian clock in vitro. Brain Res 808:31–41. CrossRef Medline
55. Prosser RA (1999) Melatonin inhibits in vitro serotonergic phase shifts of the suprachiasmatic circadian clock. Brain Res 818:408–413. CrossRef Medline
56. Prosser RA (2003) Serotonin phase-shifts the mouse suprachiasmatic circadian clock in vitro. Brain Res 966:110–115. CrossRef Medline
57. Racagni G, Riva MA, Popoli M (2007) The interaction between the internal clock and antidepressant efficacy. Int Clin Psychopharmacol 22:S9–S14. Medline
58. Ramgopal S, Thome-Souza S, Loddenkemper T (2013) Chronopharmacology of anti-convulsive therapy. Curr Neurol Neurosci Rep 13:339. CrossRef Medline
59. Rawashdeh O, Hudson RL, Stepien I, Dubocovich ML (2011) Circadian periods of sensitivity for ramelteon on the onset of running-wheel activity and the peak of suprachiasmatic nucleus neuronal firing rhythms in C3H/ HeN mice. Chronobiol Int 28:31–38. CrossRef Medline
60. Rivera-Bermudez MA, Gerdin MJ, Earnest DJ, Dubocovich ML (2003) Regulation of basal rhythmicity in protein kinase C activity by melatonin in immortalized rat suprachiasmatic nucleus cells. Neurosci Lett 346(1–2):37–40.
61. Rivera-Bermudez MA, Masana MI, Brown GM, Earnest DJ, Dubocovich ML (2004) Immortalized cells from the rat suprachiasmatic nucleus express functional melatonin receptors. Brain Res 1002(1–2):21–27.
62. Roenneberg T, MerrowM (2005) Circadian clocks–the fall and rise of physiology. Nat Rev Mol Cell Biol 6:965–971.CrossRef
63. Ruiz de Elvira MC, Persaud R, Coen CW (1992) Use of running wheels regulates the effects of the ovaries on circadian rhythms. Physiol Behav 52:277–284. CrossRef Medline
64. Schaap J, Bos NP, de Jeu MT, Geurtsen AM, Meijer JH, Pennartz CM (1999) Neurons of the rat suprachiasmatic nucleus show a circadian rhythm in membrane properties that is lost during prolonged whole-cell recording. Brain Res 815:154–166. CrossRef Medline
65. Scott FF, Belle MD, Delagrange P, Piggins HD (2010) Electrophysiological effects of melatonin on mouse Per1 and non-Per1 suprachiasmatic nuclei neurones in vitro. J Neuroendocrinol 22:1148–1156. CrossRef Medline
66. Shimomura K, Lowrey PL, Vitaterna MH, Buhr ED, Kumar V, Hanna P, Omura C, Izumo M, Low SS, Barrett RK, LaRue SI, Green CB, Takahashi JS (2010) Genetic suppression of the circadian Clock mutation by the melatonin biosynthesis pathway. Proc Natl Acad Sci U S A 107:8399–8403. CrossRef Medline
67. Signorini S, Liao YJ, Duncan SA, Jan LY, Stoffe lM (1997) Normal cerebellar development but susceptibility to seizures in mice lacking G proteincoupled, inwardly rectifying K channel GIRK2. Proc Natl Acad Sci U S A 94:923–927. CrossRef Medline
68. Siuciak JA, Fang JM, Dubocovich ML (1990) Autoradiographic localization of 2-[125I]iodomelatonin binding sites in the brains of C3H/HeN and C57BL/6J strains of mice. Eur J Pharmacol 180:387–390. CrossRef Medline
69. Srinivasan V, De Berardis D, Shillcutt SD, Brzezinski A (2012) Role of melatonin in mood disorders and the antidepressant effects of agomelatine. Expert Opin Investig Drugs 21:1503–1522. CrossRef Medline
70. Stores G, Stores R (2012) Sleep disorders and their clinical significance in children with Down syndrome. Dev Med Child Neurol 55:126–130. CrossRef Medline
71. Turek FW, Penev P, Zhang Y, van Reeth O, Zee P (1995) Effects of age on the circadian system. Neurosci Biobehav Rev 19:53–58. CrossRef Medline
72. Uberos J, Romero J, Molina-Carballo A, Muñoz-Hoyos A (2010) Melatonin and elimination of kynurenines in children with Down’s syndrome. J Pediatr Endocrinol Metab 23:277–282. Medline
73. van den Pol AN (2012) Neuropeptide transmission in brain circuits. Neuron 76:98–115. CrossRef Medline
74. van den Top M, Buijs RM, Ruijter JM, Delagrange P, Spanswick D, Hermes ML (2001) Melatonin generates an outward potassium current in rat suprachiasmatic nucleus neurones in vitro independent of their circadian rhythm. Neuroscience 107:99–108. CrossRef Medline
75. Vyazovskiy VV, Kopp C, Wigger E, Jones ME, Simpson ER, Tobler I (2006) Sleep and rest regulation in young and old oestrogen-deficient female mice. J Neuroendocrinol 18:567–576. CrossRef Medline
76. Webb IC, Lehman MN, Coolen LM (2015) Diurnal and circadian regulation of reward-related neurophysiology and behavior. Physiol Behav 143: 58–69. CrossRef Medline
77. Wu YH, Ursinus J, Zhou JN, Scheer FA, Ai-Min B, Jockers R, van Heerikhuize J, Swaab DF (2013) Alterations of melatonin receptors MT1 and MT2 in the hypothalamic suprachiasmatic nucleus during depression. J Affect Disord 148:357–367. CrossRef Medline
78. Wydeven N, Marron Fernandez de Velasco E, Du Y, Benneyworth MA, Hearing MC, Fischer RA, Thomas MJ, Weaver CD, Wickman K (2014) Mechanisms underlying the activation of G-protein-gated inwardly rectifying K (GIRK) channels by the novel anxiolytic drug, ML297. Proc Natl Acad Sci U S A 111:10755–10760. CrossRef Medline
79. Zarowski M, Loddenkemper T, Vendrame M, Alexopoulos AV, Wyllie E, Kothare SV (2011) Circadian distribution and sleep/wake patterns of generalized seizures in. Epilepsia 52:1076–1083. CrossRef Medline
80. Zhou XJ, Jiang XH, Yu GD, Yin QZ (2000) Modulation of circadian rhythm of discharges of suprachiasmatic nucleus neurons in rat hypothalamic slices by melatonin. Sheng Li Xue Bao 52:215–219. Medline